Logo image of PCT

PURECYCLE TECHNOLOGIES INC (PCT) Stock Fundamental Analysis

USA - NASDAQ:PCT - US74623V1035 - Common Stock

9.6 USD
-0.29 (-2.93%)
Last: 11/12/2025, 8:00:00 PM
9.63 USD
+0.03 (+0.31%)
Pre-Market: 11/13/2025, 4:45:41 AM
Fundamental Rating

2

Taking everything into account, PCT scores 2 out of 10 in our fundamental rating. PCT was compared to 82 industry peers in the Chemicals industry. PCT has a bad profitability rating. Also its financial health evaluation is rather negative. PCT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PCT has reported negative net income.
In the past year PCT has reported a negative cash flow from operations.
In the past 5 years PCT always reported negative net income.
PCT had a negative operating cash flow in each of the past 5 years.
PCT Yearly Net Income VS EBIT VS OCF VS FCFPCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

PCT has a Return On Assets of -27.89%. This is amonst the worse of the industry: PCT underperforms 90.24% of its industry peers.
Looking at the Return On Equity, with a value of -73.99%, PCT is doing worse than 84.15% of the companies in the same industry.
Industry RankSector Rank
ROA -27.89%
ROE -73.99%
ROIC N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
PCT Yearly ROA, ROE, ROICPCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCT Yearly Profit, Operating, Gross MarginsPCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

3

2. Health

2.1 Basic Checks

PCT has more shares outstanding than it did 1 year ago.
PCT has more shares outstanding than it did 5 years ago.
PCT has a better debt/assets ratio than last year.
PCT Yearly Shares OutstandingPCT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PCT Yearly Total Debt VS Total AssetsPCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.29, we must say that PCT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.29, PCT is doing worse than 80.49% of the companies in the same industry.
PCT has a Debt/Equity ratio of 0.89. This is a neutral value indicating PCT is somewhat dependend on debt financing.
The Debt to Equity ratio of PCT (0.89) is worse than 60.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 0.29
ROIC/WACCN/A
WACCN/A
PCT Yearly LT Debt VS Equity VS FCFPCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 2.14 indicates that PCT has no problem at all paying its short term obligations.
PCT has a Current ratio (2.14) which is comparable to the rest of the industry.
A Quick Ratio of 2.07 indicates that PCT has no problem at all paying its short term obligations.
The Quick ratio of PCT (2.07) is better than 80.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.07
PCT Yearly Current Assets VS Current LiabilitesPCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

PCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.31%.
EPS 1Y (TTM)-16.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PCT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.59% yearly.
Based on estimates for the next years, PCT will show a very strong growth in Revenue. The Revenue will grow by 193.22% on average per year.
EPS Next Y22.32%
EPS Next 2Y25.14%
EPS Next 3Y16.46%
EPS Next 5Y16.6%
Revenue Next Year700.18%
Revenue Next 2Y510.93%
Revenue Next 3Y284.93%
Revenue Next 5Y193.22%

3.3 Evolution

PCT Yearly Revenue VS EstimatesPCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500M 1B 1.5B 2B
PCT Yearly EPS VS EstimatesPCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCT. In the last year negative earnings were reported.
Also next year PCT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCT Price Earnings VS Forward Price EarningsPCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCT Per share dataPCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PCT's earnings are expected to grow with 16.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.14%
EPS Next 3Y16.46%

0

5. Dividend

5.1 Amount

PCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (11/12/2025, 8:00:00 PM)

Premarket: 9.63 +0.03 (+0.31%)

9.6

-0.29 (-2.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners72.98%
Inst Owner Change-0.61%
Ins Owners2.85%
Ins Owner Change0.17%
Market Cap1.73B
Revenue(TTM)N/A
Net Income(TTM)-290.73M
Analysts76
Price Target17.68 (84.17%)
Short Float %20.15%
Short Ratio13.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.02%
Min EPS beat(2)-285.57%
Max EPS beat(2)121.52%
EPS beat(4)1
Avg EPS beat(4)-99.62%
Min EPS beat(4)-285.57%
Max EPS beat(4)121.52%
EPS beat(8)3
Avg EPS beat(8)-59.39%
EPS beat(12)4
Avg EPS beat(12)-58.93%
EPS beat(16)5
Avg EPS beat(16)-46.25%
Revenue beat(2)0
Avg Revenue beat(2)-58.31%
Min Revenue beat(2)-60.11%
Max Revenue beat(2)-56.51%
Revenue beat(4)0
Avg Revenue beat(4)-79.15%
Min Revenue beat(4)-100%
Max Revenue beat(4)-56.51%
Revenue beat(8)0
Avg Revenue beat(8)-89.58%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7%
PT rev (3m)23.81%
EPS NQ rev (1m)4.76%
EPS NQ rev (3m)-37.28%
EPS NY rev (1m)3.71%
EPS NY rev (3m)-133.87%
Revenue NQ rev (1m)-3.66%
Revenue NQ rev (3m)-48.93%
Revenue NY rev (1m)-2.76%
Revenue NY rev (3m)-30.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 535.25
P/FCF N/A
P/OCF N/A
P/B 4.4
P/tB 4.4
EV/EBITDA N/A
EPS(TTM)-1.59
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS0.02
BVpS2.18
TBVpS2.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.89%
ROE -73.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 184.6%
Cap/Sales 1686.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 2.07
Altman-Z 0.29
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3032.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.52%
EPS Next Y22.32%
EPS Next 2Y25.14%
EPS Next 3Y16.46%
EPS Next 5Y16.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year700.18%
Revenue Next 2Y510.93%
Revenue Next 3Y284.93%
Revenue Next 5Y193.22%
EBIT growth 1Y-27.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.83%
EBIT Next 3Y29.3%
EBIT Next 5Y32%
FCF growth 1Y45.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-98.85%
OCF growth 3YN/A
OCF growth 5YN/A

PURECYCLE TECHNOLOGIES INC / PCT FAQ

What is the fundamental rating for PCT stock?

ChartMill assigns a fundamental rating of 2 / 10 to PCT.


What is the valuation status of PURECYCLE TECHNOLOGIES INC (PCT) stock?

ChartMill assigns a valuation rating of 0 / 10 to PURECYCLE TECHNOLOGIES INC (PCT). This can be considered as Overvalued.


Can you provide the profitability details for PURECYCLE TECHNOLOGIES INC?

PURECYCLE TECHNOLOGIES INC (PCT) has a profitability rating of 0 / 10.


What is the financial health of PURECYCLE TECHNOLOGIES INC (PCT) stock?

The financial health rating of PURECYCLE TECHNOLOGIES INC (PCT) is 3 / 10.